Jingjing Li
-
- Traditional Chinese Medicine Analysis 9
- Natural Compounds in Disease Treatment 9
- Andrographolide Research and Applications 8
- Pharmacology top 1%
- Pharmacological Effects of Natural Compounds 16
- Fungal Biology and Applications 8
- Molecular Medicine top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 10
- Cancer Research top 5%
-
- Natural product bioactivities and synthesis 9
-
- Bioactive Compounds and Antitumor Agents 7
Jingjing Li
219 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 183
- Complementary and alternative medicine 338
- Pharmacology 353
- Molecular Medicine 146
- Biomaterials 382
- Cancer Research 420
Countries citing papers authored by Jingjing Li
This map shows the geographic impact of Jingjing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Li more than expected).
Fields of papers citing papers by Jingjing Li
This network shows the impact of papers produced by Jingjing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Li. The network helps show where Jingjing Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingjing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 15 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 18 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 17 | |
| 15 | 2023 | 10 | |
| 16 | 2023 | 7 | |
| 17 | 2023 | 13 | |
| 18 | 2023 | 23 | |
| 19 | 2022 | 10 | |
| 20 | 2010 | 26 |
About Jingjing Li
Jingjing Li is a scholar working on Complementary and alternative medicine, Pharmacology and Toxicology, having authored 240 papers that have together received 5.0k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (16 papers), Nanoparticle-Based Drug Delivery (10 papers), Traditional Chinese Medicine Analysis (9 papers), Natural product bioactivities and synthesis (9 papers), Natural Compounds in Disease Treatment (9 papers), Andrographolide Research and Applications (8 papers), Fungal Biology and Applications (8 papers) and Bioactive Compounds and Antitumor Agents (7 papers). The work is most often cited by research in Complementary and alternative medicine (338 citations), Pharmacology (353 citations) and Molecular Medicine (146 citations). Jingjing Li has collaborated with scholars based in China, Hong Kong and Macao. Frequent co-authors include Jinming Zhang, Chaomei Fu, Gph Leung, Simon Ming‐Yuen Lee, Jiannong Cao, Yuhui Shi, Jun Zhang, Henry Shu-Hung Chung, Zhi‐Hui Zhan and Yihan Wu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.